Enfortumab Vedotin Induced Hyperglycemia and Diabetic Ketoacidosis

被引：0
|
作者：
Patel, J. [1 ]
机构：
[1] Rush Univ, Med Ctr, Pulm & Crit Care Med, Chicago, IL 60612 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5298
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Canagliflozin induced Diabetic Ketoacidosis
    Kumar, D.
    Tudor, R.
    Berzan, E.
    Nasim, M. Z.
    Shah, S. A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S372 - S372
  • [42] Enfortumab vedotin-induced toxic epidermal necrolysis: A rare fatal adverse reaction
    Bansal, Aditi
    Singh, Jagdeep
    Kaur, Sukhjot
    Kaur, Navneet
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2022, 13 (01) : 128 - 130
  • [43] Enfortumab vedotin in the treatment of urothelial cancers and beyond
    Wong, Risa L.
    Yu, Evan Y.
    FUTURE ONCOLOGY, 2022, 18 (27) : 3067 - 3084
  • [44] Increased risk of hyperglycemia in patients with advanced urothelial cancer treated with enfortumab vedotin: A systematic review and meta-analysis
    Cheng, Ryan
    Boparai, Montek
    Wu, Shenhong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
    Powles, Thomas
    Rosenberg, Jonathan E.
    Sonpavde, Guru P.
    Loriot, Yohann
    Duran, Ignacio
    Lee, Jae-Lyun
    Matsubara, Nobuaki
    Vulsteke, Christof
    Castellano, Daniel
    Wu, Chunzhang
    Campbell, Mary
    Matsangou, Maria
    Petrylak, Daniel P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1125 - 1135
  • [46] Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?
    Maiorano, Brigida Anna
    Catalano, Martina
    Maiello, Evaristo
    Roviello, Giandomenico
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [47] Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia
    Sooy, Morgan
    Pyle, Laura
    Alonso, Guy Todd
    Broncucia, Hali C.
    Rewers, Arleta
    Gottlieb, Peter A.
    Simmons, Kimber M.
    Rewers, Marian J.
    Steck, Andrea K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [48] A Diabetic Ketoacidosis (DKA) Power Plan to Reduce Frequency of Rebound Hyperglycemia
    Manroa, Pooja
    Morariu, Elena
    Salata, Roseann J.
    Donihi, Amy C.
    Reider, Jodie A.
    Codario, Ronald
    Acharya, Runa
    Korytkowski, Mary T.
    DIABETES, 2016, 65 : A315 - A315
  • [49] Transient Ventriculomegaly in an Adolescent Presenting with Shunted Hydrocephalus, Diabetic Ketoacidosis, and Hyperglycemia
    Gruber, Thomas J.
    Rozzelle, Curtis J.
    PEDIATRIC NEUROSURGERY, 2008, 44 (06) : 496 - 500
  • [50] CLINICAL AND METABOLIC FACTORS INFLUENCING DURATION OF HYPERGLYCEMIA IN DIABETIC KETOACIDOSIS (DKA)
    KITABCHI, AE
    GUERRA, SMO
    AYYAGARI, V
    CLINICAL RESEARCH, 1976, 24 (03): : A486 - A486
12345